{"id":187,"date":"2026-09-14T02:00:02","date_gmt":"2026-09-14T06:00:02","guid":{"rendered":"https:\/\/pauseproof.com\/articles\/?p=187"},"modified":"2026-11-17T01:00:06","modified_gmt":"2026-11-17T06:00:06","slug":"symptoms-of-ovarian-cancer-after-menopause","status":"publish","type":"post","link":"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/","title":{"rendered":"Symptoms of Ovarian Cancer After Menopause: When to Act"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>The symptoms of ovarian cancer after menopause are bloating that stays, feeling full quickly, pelvic or tummy pain, and needing to pee more urgently or often. None is unusual alone. NICE guidance says tests are due when they are persistent or frequent, particularly more than 12 times a month, especially from age 50.<\/strong><\/p>\n\n\n\n<div class=\"msq-audio\" data-article=\"symptoms-of-ovarian-cancer-after-menopause\" data-minutes=\"17\">\n<style>.msq-audio{margin:1.25em 0 1.75em;padding:16px 18px;background:#F5EFF5;border:1px solid #DDD0DF;border-radius:12px}\n.msq-audio-lead{margin:0 0 8px;font-size:.95em}.msq-audio audio{width:100%;margin:0 0 12px;display:block}\n.msq-toc-title{margin:0 0 6px;font-weight:700}.msq-toc ol{margin:0;padding:0;list-style:none}\n.msq-toc li{display:flex;gap:10px;align-items:center;padding:6px 6px;border-bottom:1px solid #DDD0DF;border-radius:8px}\n.msq-toc li:last-child{border-bottom:0}.msq-toc li.is-active{background:#fff}\n.msq-toc-play{flex:0 0 auto;width:30px;height:30px;border-radius:50%;border:0;background:#5E3870;color:#fff;font:inherit;font-size:.72em;line-height:30px;padding:0;cursor:pointer}\n.msq-toc-play.is-playing{background:#B85F33}\n.msq-toc-time{flex:0 0 auto;min-width:3.1em;font-variant-numeric:tabular-nums;color:#544C5E;font-size:.9em}\n.msq-toc a{color:#1B1F24;text-decoration:none;line-height:1.35}.msq-toc li.is-active a{font-weight:700;color:#5E3870}\n.msq-audio-note{margin:10px 0 0;font-size:.82em;color:#544C5E}\nh2.wp-block-heading[id]{scroll-margin-top:24px}\n.msq-hplay{display:inline-block;vertical-align:middle;width:26px;height:26px;margin:0 0 0 10px;border-radius:50%;border:0;background:#5E3870;cursor:pointer;padding:0;position:relative;top:-2px}\n.msq-hplay::before{content:'\u25b6\ufe0e';display:block;color:#fff;font-size:11px;line-height:26px;text-align:center}\n.msq-hplay.is-playing{background:#B85F33}.msq-hplay.is-playing::before{content:'\u2016';font-size:13px;font-weight:700}\n.msq-bar{position:fixed;left:0;right:0;bottom:0;z-index:9000;display:flex;align-items:center;gap:10px;padding:8px 12px;padding-bottom:calc(8px + env(safe-area-inset-bottom));background:#FFFFFF;border-top:1px solid #DDD0DF;box-shadow:0 -4px 16px rgba(0,0,0,.08);font-size:.92em;color:#1B1F24;transition:transform .2s ease}\n.msq-bar.is-hidden{transform:translateY(130%)}\n.msq-bar-play{display:inline-flex;align-items:center;gap:8px;border:0;border-radius:999px;background:#5E3870;color:#fff;font:inherit;font-weight:700;padding:8px 14px 8px 12px;cursor:pointer;white-space:nowrap}\n.msq-bar-play.is-playing{background:#B85F33}\n.msq-bar-icon::before{content:'\u25b6\ufe0e';font-size:12px}.msq-bar-play.is-playing .msq-bar-icon::before{content:'\u2016';font-size:14px;font-weight:700}\n.msq-bar-chapter{flex:1 1 auto;min-width:0;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}\n.msq-bar-time{flex:0 0 auto;font-variant-numeric:tabular-nums;color:#544C5E;font-size:.9em}\n.msq-bar-rate,.msq-bar-close{flex:0 0 auto;border:1px solid #DDD0DF;background:#fff;color:#1B1F24;font:inherit;font-size:.85em;line-height:1;border-radius:8px;padding:7px 9px;cursor:pointer}\n.msq-bar-close::before{content:'\u2715'}\n.msq-bar.msq-bar-pill{left:auto;right:14px;bottom:14px;padding:6px;padding-bottom:6px;border:1px solid #DDD0DF;border-radius:999px;box-shadow:0 6px 20px rgba(0,0,0,.15)}\n.msq-bar.msq-bar-pill .msq-bar-chapter,.msq-bar.msq-bar-pill .msq-bar-time,.msq-bar.msq-bar-pill .msq-bar-rate{display:none}\nbody.msq-has-bar{padding-bottom:76px}\n@media (max-width:600px){.msq-bar-time{display:none}.msq-bar{gap:8px;padding-left:10px;padding-right:10px}}\n.msq-s.msq-now{background:#F5EFF5;box-shadow:0 2px 0 #5E3870;border-radius:2px}\ntr.msq-now td,tr.msq-now th{background:#F5EFF5;box-shadow:inset 0 -2px 0 #5E3870}\n@media (hover:hover){.msq-s,tr[data-i]{cursor:pointer}.msq-s:hover{background:#F5EFF5}}<\/style>\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"AudioObject\",\"@id\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#audio\",\"name\":\"Symptoms of Ovarian Cancer After Menopause: When to Act, read aloud\",\"description\":\"Synthetic voice reading of the article, recorded 17 November 2026.\",\"contentUrl\":\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/11\/symptoms-of-ovarian-cancer-after-menopause-audio-202611171129.mp3\",\"encodingFormat\":\"audio\/mpeg\",\"duration\":\"PT16M39S\",\"uploadDate\":\"2026-11-17\",\"inLanguage\":\"en-GB\",\"isAccessibleForFree\":true,\"mainEntityOfPage\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/\",\"hasPart\":[{\"@type\":\"Clip\",\"name\":\"Symptoms of Ovarian Cancer After Menopause: When to Act\",\"startOffset\":0,\"endOffset\":58},{\"@type\":\"Clip\",\"name\":\"What are the symptoms of ovarian cancer after menopause?\",\"startOffset\":58,\"endOffset\":160,\"url\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#what-are-the-symptoms-of-ovarian-cancer-after-menopause\"},{\"@type\":\"Clip\",\"name\":\"How is this different from ordinary menopause bloating?\",\"startOffset\":160,\"endOffset\":277,\"url\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#how-is-this-different-from-ordinary-menopause-bloating\"},{\"@type\":\"Clip\",\"name\":\"Where does more than 12 times a month come from?\",\"startOffset\":277,\"endOffset\":416,\"url\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#where-does-more-than-12-times-a-month-come-from\"},{\"@type\":\"Clip\",\"name\":\"What test does the pattern lead to?\",\"startOffset\":416,\"endOffset\":650,\"url\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#what-test-does-the-pattern-lead-to\"},{\"@type\":\"Clip\",\"name\":\"Why is there no screening test to catch it earlier?\",\"startOffset\":650,\"endOffset\":682,\"url\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#why-is-there-no-screening-test-to-catch-it-earlier\"},{\"@type\":\"Clip\",\"name\":\"How common is ovarian cancer after menopause?\",\"startOffset\":682,\"endOffset\":815,\"url\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#how-common-is-ovarian-cancer-after-menopause\"},{\"@type\":\"Clip\",\"name\":\"What do people who went through this report?\",\"startOffset\":815,\"endOffset\":946,\"url\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#what-do-people-who-went-through-this-report\"},{\"@type\":\"Clip\",\"name\":\"What if the tests were normal and the symptoms carry on?\",\"startOffset\":946,\"endOffset\":999,\"url\":\"https:\/\/pauseproof.com\/articles\/symptoms-of-ovarian-cancer-after-menopause\/#what-if-the-tests-were-normal-and-the-symptoms-carry-on\"}],\"contentSize\":\"7.0 MB\"}<\/script>\n<p class=\"msq-audio-lead\"><strong>Listen to this article<\/strong>, about 17 minutes. A synthetic voice reads the article and announces each section title as it begins; tables are read row by row and the questions at the end are left out.<\/p>\n<audio class=\"msq-audio-player\" controls preload=\"metadata\" src=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/11\/symptoms-of-ovarian-cancer-after-menopause-audio-202611171129.mp3\"><\/audio>\n<nav class=\"msq-toc\" aria-label=\"In this article\"><p class=\"msq-toc-title\">In this article<\/p>\n<ol>\n<li data-start=\"0.0\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"0.0\" aria-label=\"Play from: Symptoms of Ovarian Cancer After Menopause: When to Act\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">0:00<\/span><a href=\"#top\">Symptoms of Ovarian Cancer After Menopause: When to Act<\/a><\/li>\n<li data-start=\"57.54\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"57.54\" aria-label=\"Play from: What are the symptoms of ovarian cancer after menopause?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">0:58<\/span><a href=\"#what-are-the-symptoms-of-ovarian-cancer-after-menopause\">What are the symptoms of ovarian cancer after menopause?<\/a><\/li>\n<li data-start=\"160.2\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"160.2\" aria-label=\"Play from: How is this different from ordinary menopause bloating?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">2:40<\/span><a href=\"#how-is-this-different-from-ordinary-menopause-bloating\">How is this different from ordinary menopause bloating?<\/a><\/li>\n<li data-start=\"276.74\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"276.74\" aria-label=\"Play from: Where does more than 12 times a month come from?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">4:37<\/span><a href=\"#where-does-more-than-12-times-a-month-come-from\">Where does more than 12 times a month come from?<\/a><\/li>\n<li data-start=\"416.4\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"416.4\" aria-label=\"Play from: What test does the pattern lead to?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">6:56<\/span><a href=\"#what-test-does-the-pattern-lead-to\">What test does the pattern lead to?<\/a><\/li>\n<li data-start=\"649.5\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"649.5\" aria-label=\"Play from: Why is there no screening test to catch it earlier?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">10:50<\/span><a href=\"#why-is-there-no-screening-test-to-catch-it-earlier\">Why is there no screening test to catch it earlier?<\/a><\/li>\n<li data-start=\"681.56\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"681.56\" aria-label=\"Play from: How common is ovarian cancer after menopause?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">11:22<\/span><a href=\"#how-common-is-ovarian-cancer-after-menopause\">How common is ovarian cancer after menopause?<\/a><\/li>\n<li data-start=\"815.26\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"815.26\" aria-label=\"Play from: What do people who went through this report?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">13:35<\/span><a href=\"#what-do-people-who-went-through-this-report\">What do people who went through this report?<\/a><\/li>\n<li data-start=\"946.04\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"946.04\" aria-label=\"Play from: What if the tests were normal and the symptoms carry on?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">15:46<\/span><a href=\"#what-if-the-tests-were-normal-and-the-symptoms-carry-on\">What if the tests were normal and the symptoms carry on?<\/a><\/li>\n<\/ol><\/nav>\n<p class=\"msq-audio-note\">Recorded 17 November 2026 from the article as published that day. Press a chapter to jump there; the highlighted line is what is playing. A play button sits beside every section heading, and once you scroll past this player a bar at the bottom of the screen keeps the controls in reach. Tap or click any sentence to hear the reading start from there.<\/p>\n<script>var MSQ_SENT = [[0.0,\"h\",\"symptomsofovariancancera\",46],[3.48,\"p\",\"thesymptomsofovariancanc\",129],[13.2,\"p\",\"noneisunusualalone\",18],[15.6,\"p\",\"niceguidancesaystestsare\",110],[23.2,\"p\",\"onthispagetheca125thresh\",146],[36.72,\"p\",\"mostsymptomlistsstopbefo\",150],[47.48,\"p\",\"whatguidanceusesisthepat\",57],[52.4,\"p\",\"thisarticlesetsthatpatte\",29],[54.24,\"p\",\"itcannottellanyonewhatth\",42],[57.54,\"h\",\"whatarethesymptomsofovar\",47],[60.7,\"p\",\"thenhsovariancancersympt\",238],[79.62,\"p\",\"itlistsothersymptomstooi\",143],[91.3,\"p\",\"constipationonitsownfarm\",141],[100.94,\"p\",\"theukguidelineforgpsuses\",35],[104.3,\"p\",\"niceguidelineng12onsuspe\",258],[126.54,\"p\",\"whatchangeswithageisthel\",107],[133.98,\"p\",\"bleedingistheexceptionto\",46],[136.7,\"p\",\"anybleedingaftertwelvemo\",122],[144.74,\"p\",\"thattwelvemonthlineisals\",114],[151.38,\"p\",\"ifthosetwelvemonthsarriv\",123],[160.2,\"h\",\"howisthisdifferentfromor\",47],[163.04,\"p\",\"bloatingiscommonwhichise\",40],[165.6,\"p\",\"theromefoundationglobale\",119],[176.32,\"p\",\"ourarticleonthegutchange\",88],[181.84,\"p\",\"thetablebelowsetsthetwop\",41],[185.16,\"p\",\"itsummariseshowguidances\",135],[194.8,\"t\",\"howoften\",184],[211.48,\"t\",\"hownew\",168],[227.08,\"t\",\"bowelsymptoms\",205],[244.88,\"t\",\"howmanytogether\",191],[260.28,\"t\",\"direction\",197],[276.74,\"h\",\"wheredoesmorethan12times\",38],[279.46,\"p\",\"fromasymptomstudypublish\",32],[282.26,\"p\",\"goffandcolleagueswriting\",248],[298.7,\"p\",\"theirindexcountedasposit\",102],[304.94,\"p\",\"intheconfirmatorysamplei\",75],[313.14,\"p\",\"itsspecificitywas90inwom\",117],[322.26,\"p\",\"asymptomruleisafilterfor\",36],[324.7,\"p\",\"itisnotadiagnosisineithe\",34],[327.1,\"p\",\"hereishowthethresholdrea\",70],[333.02,\"t\",\"niceng12suspectedcancer\",230],[354.26,\"t\",\"nicecg122ovariancancer\",189],[373.98,\"t\",\"nhssymptomspage\",148],[388.38,\"t\",\"goffsymptomindex\",120],[400.42,\"t\",\"uspreventiveservicestask\",172],[416.4,\"h\",\"whattestdoesthepatternle\",28],[418.36,\"p\",\"intheukabloodtestfirstfo\",43],[422.2,\"p\",\"niceamendedtheovariancan\",192],[439.24,\"p\",\"beforethatupdateonefigur\",48],[444.72,\"p\",\"from50upwardseveryageban\",44],[447.76,\"p\",\"ifthescansuggestsovarian\",103],[454.08,\"t\",\"39orunder\",153],[475.88,\"t\",\"40to49\",104],[495.48,\"t\",\"50to59\",104],[512.6,\"t\",\"60to69\",104],[530.8,\"t\",\"70to79\",104],[549.84,\"t\",\"80andover\",107],[568.76,\"p\",\"thecommitteeexplainsitsr\",55],[571.96,\"p\",\"moderatecertaintyevidenc\",166],[584.92,\"p\",\"pageswrittenbeforeapril2\",55],[590.4,\"p\",\"thisonedidtoountilwechec\",60],[596.12,\"p\",\"ca125isapointernotaverdi\",26],[599.76,\"p\",\"astudyof50780womentested\",201],[619.72,\"p\",\"mostraisedresultswerenei\",28],[621.36,\"p\",\"thatstudyusedtheoldsingl\",77],[628.44,\"p\",\"aresultbelowthethreshold\",58],[631.8,\"p\",\"underrecommendation1511w\",200],[649.5,\"h\",\"whyistherenoscreeningtes\",41],[652.02,\"p\",\"becausethelargesttrialto\",44],[655.18,\"p\",\"ukctocsreportedinthelanc\",85],[665.02,\"p\",\"screeningfoundsomecancer\",66],[669.22,\"p\",\"theuspreventiveservicest\",116],[676.58,\"p\",\"thatleavessymptomsandthe\",54],[681.56,\"h\",\"howcommonisovariancancer\",38],[684.28,\"p\",\"lesscommonthantheworryit\",50],[687.84,\"p\",\"theamericancancersociety\",112],[698.56,\"p\",\"intheukcancerresearchukc\",46],[704.36,\"p\",\"thefigurethatexplainswhy\",80],[709.24,\"p\",\"inenglandin202238ofcases\",64],[716.32,\"p\",\"ofcasesdiagnosedinenglan\",193],[733.0,\"t\",\"newdiagnosesayearus\",86],[743.0,\"t\",\"lifetimeriskus\",70],[750.88,\"t\",\"womendiagnosedwhoare63or\",86],[759.8,\"t\",\"newcasesayearuk\",73],[771.96,\"t\",\"stagedcasesfoundatstagei\",78],[781.44,\"t\",\"diagnosedthroughanurgent\",97],[791.6,\"t\",\"diagnosedthroughanemerge\",89],[801.16,\"p\",\"thosenumbersdescribepopu\",46],[804.64,\"p\",\"theydoshowwhythesymptomr\",150],[815.26,\"h\",\"whatdopeoplewhowentthrou\",36],[817.1,\"p\",\"forthisarticlewereadtwop\",98],[824.34,\"p\",\"twodescribedeventsmoreth\",52],[827.5,\"p\",\"thesevenbelowarewhatpeop\",85],[833.38,\"p\",\"inathreadinrmenopausepos\",160],[846.62,\"p\",\"shesaidshehadraiseditwit\",156],[856.14,\"p\",\"shedidnotpostanoutcome\",22],[857.54,\"p\",\"onereplydescribedsimilar\",139],[866.66,\"p\",\"anotherdescribedahaemorr\",81],[871.82,\"p\",\"athirdsaidhermotherssimi\",123],[879.78,\"p\",\"inrovariancancerunderapo\",151],[891.86,\"p\",\"anotherdescribed16months\",155],[902.1,\"p\",\"athirdcutagainstthewhole\",127],[910.94,\"p\",\"herworrywasthatwomenwith\",66],[914.66,\"p\",\"wheretheaccountsagreewit\",222],[932.5,\"p\",\"wheretheypartcompanytheg\",136],[941.9,\"p\",\"noneofthesestoriessaysan\",64],[946.04,\"h\",\"whatifthetestswerenormal\",45],[948.84,\"p\",\"thentheyareworthraisinga\",28],[950.48,\"p\",\"nicebuildsthatreturnvisi\",114],[958.2,\"p\",\"awrittenrecordmakesthats\",106],[966.12,\"p\",\"fortheotherchangesthatca\",71],[970.76,\"p\",\"ifanyofthesesymptomsareh\",73],[975.72,\"p\",\"suddensevereabdominalpai\",106],[983.64,\"p\",\"ifyouarenotsurewhetheryo\",91],[989.0,\"p\",\"thisarticleisgeneralinfo\",109],[995.72,\"p\",\"speaktoyourdoctoraboutyo\",38]];\n(function(){\n  function init(){\n  var root = document.querySelector('.msq-audio'); if (!root) { return; }\n  var audio = root.querySelector('audio'), items = Array.prototype.slice.call(root.querySelectorAll('.msq-toc li'));\n  var starts = items.map(function(li){ return parseFloat(li.getAttribute('data-start')) || 0; });\n  var names = items.map(function(li){ return li.querySelector('a').textContent; });\n  var anchors = items.map(function(li){ var h = li.querySelector('a').getAttribute('href') || ''; return (h.charAt(0) === '#' && h !== '#top') ? document.getElementById(h.slice(1)) : null; });\n  var article = root.getAttribute('data-article') || location.pathname, minutes = root.getAttribute('data-minutes') || '';\n  var marks = {}, started = false, pausedAt = -1, closed = false, ended = false;\n  var RATES = [1, 1.25, 1.5], rate = 1;\n  try { var saved = parseFloat(localStorage.getItem('msq-audio-rate')); if (RATES.indexOf(saved) >= 0) { rate = saved; } } catch (e) {}\n  audio.playbackRate = rate;\n  function track(name, extra){ try { if (typeof gtag === 'function') { var p = { article: article }; for (var k in extra) { p[k] = extra[k]; } gtag('event', name, p); } } catch (e) {} }\n  function current(){ var t = audio.currentTime, idx = 0; for (var i = 0; starts.length > i; i += 1) { if (t + 0.25 >= starts[i]) { idx = i; } } return idx; }\n  function onScreen(){\n    var line = window.innerHeight \/ 3, idx = 0;\n    for (var i = 0; anchors.length > i; i += 1) { var el = anchors[i]; if (el && line >= el.getBoundingClientRect().top) { idx = i; } }\n    return idx;\n  }\n  function fmt(s){ s = Math.max(0, Math.round(s || 0)); var m = Math.floor(s \/ 60), r = s % 60; return m + ':' + (10 > r ? '0' : '') + r; }\n  function play(from, source){\n    if (from !== null) { audio.currentTime = from; }\n    var p = audio.play(); if (p && p.catch) { p.catch(function(){}); }\n    track(from === null ? 'audio_resume' : 'audio_chapter', { chapter: names[current()], start: Math.round(audio.currentTime), source: source });\n  }\n  var hbtns = anchors.map(function(el, i){\n    if (!el) { return null; }\n    var b = document.createElement('button'); b.type = 'button'; b.className = 'msq-hplay'; b.setAttribute('aria-label', 'Play this section: ' + names[i]);\n    b.addEventListener('click', function(){\n      if (!audio.paused && current() === i) { audio.pause(); track('audio_pause', { source: 'heading' }); return; }\n      play(starts[i], 'heading');\n    });\n    el.appendChild(b); return b;\n  });\n  var bar = document.createElement('div'); bar.className = 'msq-bar msq-bar-pill is-hidden'; bar.setAttribute('role', 'region'); bar.setAttribute('aria-label', 'Audio player');\n  var playBtn = document.createElement('button'); playBtn.type = 'button'; playBtn.className = 'msq-bar-play';\n  var icon = document.createElement('span'); icon.className = 'msq-bar-icon'; icon.setAttribute('aria-hidden', 'true');\n  var label = document.createElement('span'); label.className = 'msq-bar-label';\n  playBtn.appendChild(icon); playBtn.appendChild(label);\n  var chap = document.createElement('span'); chap.className = 'msq-bar-chapter';\n  var clock = document.createElement('span'); clock.className = 'msq-bar-time';\n  var rateBtn = document.createElement('button'); rateBtn.type = 'button'; rateBtn.className = 'msq-bar-rate'; rateBtn.setAttribute('aria-label', 'Playback speed');\n  var closeBtn = document.createElement('button'); closeBtn.type = 'button'; closeBtn.className = 'msq-bar-close'; closeBtn.setAttribute('aria-label', 'Close the audio bar');\n  bar.appendChild(playBtn); bar.appendChild(chap); bar.appendChild(clock); bar.appendChild(rateBtn); bar.appendChild(closeBtn);\n  document.body.appendChild(bar);\n  function showRate(){ rateBtn.textContent = (rate === 1 ? '1' : String(rate)) + 'x'; }\n  showRate();\n  rateBtn.addEventListener('click', function(){\n    rate = RATES[(RATES.indexOf(rate) + 1) % RATES.length]; audio.playbackRate = rate; showRate();\n    try { localStorage.setItem('msq-audio-rate', String(rate)); } catch (e) {}\n    track('audio_rate', { rate: rate });\n  });\n  closeBtn.addEventListener('click', function(){\n    closed = true; if (!audio.paused) { audio.pause(); } paint(); track('audio_bar_close', {});\n  });\n  function mode(){\n    if (!audio.paused) { return 'pause'; }\n    if (ended) { return 'again'; }\n    if (!started) { return 'listen'; }\n    return (pausedAt === onScreen()) ? 'resume' : 'section';\n  }\n  playBtn.addEventListener('click', function(){\n    var m = mode();\n    if (m === 'pause') { audio.pause(); track('audio_pause', { source: 'bar' }); return; }\n    if (m === 'again') { ended = false; play(0, 'bar'); return; }\n    if (m === 'resume') { play(null, 'bar'); return; }\n    play(starts[onScreen()], 'bar');\n  });\n  function paint(){\n    var idx = current(), playing = !audio.paused, m = mode();\n    items.forEach(function(li, i){\n      var on = (i === idx) && playing, b = li.querySelector('.msq-toc-play'), a = li.querySelector('a');\n      li.classList.toggle('is-active', on); b.classList.toggle('is-playing', on);\n      b.textContent = on ? '\u2016' : '\u25b6\ufe0e';\n      b.setAttribute('aria-label', (on ? 'Pause: ' : 'Play from: ') + a.textContent);\n    });\n    hbtns.forEach(function(b, i){ if (b) { var on = (i === idx) && playing; b.classList.toggle('is-playing', on); b.setAttribute('aria-label', (on ? 'Pause this section: ' : 'Play this section: ') + names[i]); } });\n    playBtn.classList.toggle('is-playing', playing);\n    label.textContent = m === 'pause' ? 'Pause' : m === 'again' ? 'Play again' : m === 'resume' ? 'Resume' : m === 'section' ? 'Play this section' : 'Listen, ' + minutes + ' min';\n    playBtn.setAttribute('aria-label', label.textContent);\n    chap.textContent = started ? names[(playing || m === 'resume') ? idx : onScreen()] : '';\n    clock.textContent = started ? fmt(audio.currentTime) + ' \/ ' + fmt(audio.duration) : '';\n    bar.classList.toggle('msq-bar-pill', !started);\n    var show = !closed && (started || 0 > root.getBoundingClientRect().bottom);\n    bar.classList.toggle('is-hidden', !show);\n    document.body.classList.toggle('msq-has-bar', show);\n  }\n  root.addEventListener('click', function(e){\n    var b = e.target.closest ? e.target.closest('.msq-toc-play') : null; if (!b) { return; }\n    var li = b.parentNode, s = parseFloat(b.getAttribute('data-start')) || 0;\n    if (!audio.paused && current() === items.indexOf(li)) { audio.pause(); track('audio_pause', { source: 'index' }); return; }\n    play(s, 'index');\n  });\n  audio.addEventListener('play', function(){ ended = false; closed = false; if (!started) { started = true; track('audio_play', { minutes: Math.round((audio.duration || 0) \/ 60) }); } paint(); });\n  audio.addEventListener('pause', function(){ pausedAt = current(); paint(); });\n  audio.addEventListener('timeupdate', function(){\n    paint();\n    if (audio.duration > 0) {\n      var pct = Math.floor(audio.currentTime \/ audio.duration * 100);\n      [25, 50, 75].forEach(function(m){ if (pct >= m && !marks[m]) { marks[m] = true; track('audio_progress', { percent: m }); } });\n    }\n  });\n  audio.addEventListener('ended', function(){ ended = true; track('audio_complete', {}); paint(); });\n  var ticking = false;\n  function onScroll(){ if (ticking) { return; } ticking = true; setTimeout(function(){ ticking = false; paint(); }, 80); }\n  window.addEventListener('scroll', onScroll, { passive: true }); window.addEventListener('resize', onScroll);\n  paint();\n  }\n  if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', init); } else { init(); }\n})();\n\n(function(){\n  function start(){\n    var root = document.querySelector('.msq-audio'), audio = root ? root.querySelector('audio') : null;\n    var map = (typeof MSQ_SENT !== 'undefined') ? MSQ_SENT : [];\n    if (!root || !audio || !map.length) { return; }\n    var scope = root.closest('main') || root.closest('article') || root.closest('.entry-content') || document.body;\n    var SKIP = '.msq-audio,.msq,.msq-tool,.msq-end,.msq-bar,script,style,noscript,figcaption,#rank-math-faq,.rank-math-block,nav,header,footer';\n    function norm(s){ return s.toLowerCase().replace(\/[^a-z0-9]+\/g, ''); }\n    var nodes = [], stream = '', walker = document.createTreeWalker(scope, NodeFilter.SHOW_TEXT, null), n;\n    while ((n = walker.nextNode())) {\n      var el = n.parentElement; if (!el || el.closest(SKIP)) { continue; }\n      var raw = n.nodeValue, keep = [], norms = '';\n      for (var i = 0; raw.length > i; i += 1) { var c = raw.charAt(i).toLowerCase(); if (\/[a-z0-9]\/.test(c)) { keep.push(i); norms += c; } }\n      if (!norms) { continue; }\n      nodes.push({ node: n, a: stream.length, b: stream.length + norms.length, keep: keep });\n      stream += norms;\n    }\n    var segs = [], cursor = 0, lastRow = null;\n    map.forEach(function(m, idx){\n      var kind = m[1], f = m[2], len = m[3];\n      if (kind === 't') {\n        var rows = scope.querySelectorAll('tr'), after = !lastRow;\n        for (var r = 0; rows.length > r; r += 1) {\n          var tr = rows[r];\n          if (!after) { if (tr === lastRow) { after = true; } continue; }\n          var cell = tr.querySelector('td,th');\n          if (cell && norm(cell.textContent).indexOf(f) === 0) { tr.setAttribute('data-i', idx); lastRow = tr; break; }\n        }\n        return;\n      }\n      var p = stream.indexOf(f, cursor); if (0 > p) { return; }\n      segs.push({ i: idx, a: p, b: Math.min(p + len, stream.length) }); cursor = p + len;\n    });\n    var si = 0;\n    nodes.forEach(function(nd){\n      var frag = document.createDocumentFragment(), raw = nd.node.nodeValue, rawPos = 0, any = false;\n      for (var k = si; segs.length > k; k += 1) {\n        var sg = segs[k]; if (sg.a >= nd.b) { break; } if (nd.a >= sg.b) { continue; }\n        var s = Math.max(sg.a, nd.a), e = Math.min(sg.b, nd.b);\n        var rs = nd.keep[s - nd.a], re2 = nd.keep[e - nd.a - 1] + 1;\n        if (rs > rawPos) { frag.appendChild(document.createTextNode(raw.slice(rawPos, rs))); }\n        var span = document.createElement('span'); span.className = 'msq-s'; span.setAttribute('data-i', sg.i); span.textContent = raw.slice(rs, re2);\n        frag.appendChild(span); rawPos = re2; any = true;\n        if (sg.b > nd.b) { break; }\n      }\n      while (segs.length > si && nd.b >= segs[si].b) { si += 1; }\n      if (!any) { return; }\n      if (raw.length > rawPos) { frag.appendChild(document.createTextNode(raw.slice(rawPos))); }\n      nd.node.parentNode.replaceChild(frag, nd.node);\n    });\n    var starts = map.map(function(m){ return m[0]; }), curIdx = -1, lastUser = 0, timer = null, autoUntil = 0, dragging = false;\n    function idxAt(t){ var lo = 0, hi = starts.length; while (hi > lo + 1) { var mid = (lo + hi) >> 1; if (t + 0.15 >= starts[mid]) { lo = mid; } else { hi = mid; } } return (t + 0.15 >= starts[0]) ? lo : -1; }\n    function setNow(i){\n      if (i === curIdx) { return; }\n      Array.prototype.forEach.call(scope.querySelectorAll('.msq-now'), function(el){ el.classList.remove('msq-now'); });\n      curIdx = i; if (0 > i) { return; }\n      var els = scope.querySelectorAll('[data-i=\"' + i + '\"]'); if (!els.length) { return; }\n      Array.prototype.forEach.call(els, function(el){ el.classList.add('msq-now'); });\n      var r = els[0].getBoundingClientRect(), now = Date.now();\n      if (!dragging && now > lastUser + 2500 && (80 > r.top || r.bottom > window.innerHeight - 140)) {\n        var reduce = window.matchMedia && window.matchMedia('(prefers-reduced-motion: reduce)').matches;\n        autoUntil = now + (reduce ? 400 : 1600);\n        els[0].scrollIntoView({ block: 'center', behavior: reduce ? 'auto' : 'smooth' });\n      }\n    }\n    function tick(){ if (!audio.paused) { setNow(idxAt(audio.currentTime)); } }\n    function userScrolled(){ lastUser = Date.now(); }\n    ['wheel', 'touchmove', 'keydown'].forEach(function(ev){ window.addEventListener(ev, userScrolled, { passive: true }); });\n    window.addEventListener('scroll', function(){ if (Date.now() > autoUntil) { userScrolled(); } }, { passive: true });\n    window.addEventListener('mousedown', function(e){ if (e.clientX >= document.documentElement.clientWidth) { dragging = true; userScrolled(); } }, { passive: true });\n    window.addEventListener('mouseup', function(){ if (dragging) { dragging = false; userScrolled(); } }, { passive: true });\n    audio.addEventListener('play', function(){ if (timer) { clearInterval(timer); } timer = setInterval(tick, 150); tick(); });\n    audio.addEventListener('pause', function(){ if (timer) { clearInterval(timer); timer = null; } });\n    scope.addEventListener('click', function(e){\n      if (e.target.closest('a, button, input, select, textarea, label, summary, .msq, .msq-tool, .msq-end, .msq-audio, .msq-bar')) { return; }\n      var sel = window.getSelection ? String(window.getSelection()) : '';\n      if (sel && sel.trim()) { return; }\n      var el = e.target.closest('[data-i]'); if (!el) { return; }\n      var i = parseInt(el.getAttribute('data-i'), 10); if (isNaN(i)) { return; }\n      if (!audio.paused && i === curIdx) { return; }\n      lastUser = Date.now();\n      audio.currentTime = starts[i];\n      var p = audio.play(); if (p && p.catch) { p.catch(function(){}); }\n      try { if (typeof gtag === 'function') { gtag('event', 'audio_chapter', { article: location.pathname, source: 'sentence', start: Math.round(starts[i]) }); } } catch (err) {}\n    });\n    audio.addEventListener('seeked', tick);\n    audio.addEventListener('ended', function(){ setNow(-1); });\n  }\n  if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', start); } else { start(); }\n})();<\/script>\n<\/div>\n\n\n\n<p class=\"msq-hook wp-block-paragraph\">On this page: the CA125 thresholds by age that NICE set in April 2026, a table of bloating patterns, how common the cancer is and how it is found, and a checklist of what NICE asks about.<\/p>\n\n\n\n<div class=\"msq\" id=\"ms-quiz\" data-slug=\"symptoms-of-ovarian-cancer-after-menopause\" data-category=\"Talking To Your Doctor\" data-list=\"1\">\n<style>.msq,.msq-hook,.msq-box,.msq-end,.msq-tool{--msq-accent:#5E3870;--msq-accent-text:#FFFFFF;--msq-line:#DDD0DF;--msq-warn:#B85F33;--msq-muted:#544C5E;--msq-tint:#F5EFF5;--msq-base:#FFFFFF}\n.msq{margin:1.25em 0 1.75em}\n.msq-hook{border-left:3px solid var(--msq-accent);padding:6px 14px;color:var(--msq-muted);font-size:.97em}\n.msq-box{background:var(--msq-tint);border:1px solid var(--msq-line);border-radius:12px;padding:0}\n.msq-box>summary{cursor:pointer;list-style:none;padding:14px 18px;font-weight:700;color:var(--msq-accent)}\n.msq-box>summary::-webkit-details-marker{display:none}\n.msq-box>summary::before{content:\"+\";display:inline-block;width:1.1em;font-weight:800}\n.msq-box[open]>summary::before{content:\"\\00d7\"}\n.msq-body{padding:2px 18px 18px}\n.msq-intro{margin:0 0 12px;font-size:.95em;color:var(--msq-muted)}\n.msq-list{margin:0;padding:0;list-style:none}\n.msq-q{margin:0 0 18px;padding:0}\n.msq-question{font-weight:700;margin:0 0 8px}\n.msq-options{display:flex;flex-direction:column;gap:8px}\n.msq-opt{text-align:left;background:var(--msq-base);border:1px solid var(--msq-line);border-radius:8px;padding:10px 12px;font:inherit;font-size:.95em;color:inherit;cursor:pointer;line-height:1.35}\n.msq-opt:hover{border-color:var(--msq-accent)}\n.msq-opt[disabled]{cursor:default}\n.msq-opt.is-right{border-color:var(--msq-accent);background:var(--msq-line);font-weight:700}\n.msq-opt.is-wrong{border-color:var(--msq-warn);color:var(--msq-warn)}\n.msq-explain{margin:8px 0 0;font-size:.92em;padding:10px 12px;border-left:3px solid var(--msq-accent);background:var(--msq-base);border-radius:0 8px 8px 0}\n.msq-explain[hidden]{display:none}\n.msq-verdict{font-weight:700}\n.msq-result{margin-top:14px;padding:14px 16px;background:var(--msq-base);border:1px solid var(--msq-line);border-radius:10px}\n.msq-result[hidden]{display:none}\n.msq-result h3{margin:0 0 6px;font-size:1.1em}\n.msq-result p{margin:0 0 8px}\n.msq-jump{margin:0 0 8px;padding-left:1.2em}\n.msq-form{margin-top:10px;display:flex;flex-wrap:wrap;gap:8px;align-items:center}\n.msq-form input[type=email]{flex:1 1 220px;padding:10px 12px;border:1px solid var(--msq-muted);border-radius:8px;font:inherit;background:#fff}\n.msq-btn{background:var(--msq-accent);color:var(--msq-accent-text);border:0;border-radius:8px;padding:11px 18px;font:inherit;font-weight:700;cursor:pointer}\n.msq-btn:hover{filter:brightness(.92)}\n.msq-btn[disabled]{opacity:.7;cursor:default}\n.msq-no{font-size:.9em;color:var(--msq-muted);margin-left:4px}\n.msq-privacy{margin:6px 0 0;font-size:.82em;color:var(--msq-muted);flex-basis:100%}\n.msq-hp{position:absolute;left:-5000px;width:1px;height:1px;overflow:hidden}\n.msq-msg{margin:8px 0 0;font-size:.92em}\n.msq-end{margin:1.5em 0;padding:18px;border:1px solid var(--msq-accent);border-radius:12px;text-align:center;background:var(--msq-tint)}\n.msq-end p{margin:0 0 12px}\n.msq-end .msq-body{text-align:left;padding:16px 0 0}\n.msq-end .msq-start-test[hidden]{display:none}\n.msq-tool{margin:1.5em 0;padding:18px 20px;background:var(--msq-tint);border:1px solid var(--msq-line);border-radius:12px}\n.msq-tool h3{margin:0 0 6px;font-size:1.15em}\n.msq-tool p{margin:0 0 10px}\n.msq-tool .msq-note{font-size:.85em;color:var(--msq-muted);margin:10px 0 0}\n.msq-check label{display:flex;gap:10px;align-items:flex-start;padding:9px 0;border-bottom:1px solid var(--msq-line);cursor:pointer;line-height:1.4}\n.msq-check label:last-of-type{border-bottom:0}\n.msq-check input{margin-top:5px;flex:0 0 auto;width:18px;height:18px;accent-color:var(--msq-accent)}\n.msq-check-count{font-weight:700;margin:10px 0 0}\n.msq-verdict-box{margin:12px 0 0;padding:10px 14px;border-radius:8px;background:var(--msq-base);border-left:3px solid var(--msq-warn)}\n.msq-verdict-box[hidden]{display:none}\n.msq-calc{display:grid;grid-template-columns:1fr 1fr;gap:10px 16px}\n.msq-calc label{display:flex;flex-direction:column;gap:4px;font-size:.92em}\n.msq-calc input,.msq-calc select{padding:8px 10px;border:1px solid var(--msq-muted);border-radius:8px;font:inherit;background:#fff}\n.msq-calc-out{grid-column:1 \/ -1;margin-top:6px;padding:12px 14px;background:var(--msq-base);border-radius:8px;border:1px solid var(--msq-line)}\n.msq-calc-out strong{font-size:1.15em}\n.msq-choose label{display:block;padding:9px 12px;margin:0 0 8px;background:var(--msq-base);border:1px solid var(--msq-line);border-radius:8px;cursor:pointer}\n.msq-choose input{margin-right:8px;accent-color:var(--msq-accent)}\n.msq-choice-result{margin-top:10px;padding:12px 14px;background:var(--msq-base);border-left:3px solid var(--msq-accent);border-radius:0 8px 8px 0}\n.msq-choice-result[hidden]{display:none}\n@media (max-width:600px){.msq-calc{grid-template-columns:1fr}}\nh2.wp-block-heading[id]{scroll-margin-top:24px}<\/style>\n<noscript><style>.msq-explain{display:block !important}<\/style><\/noscript>\n<details class=\"msq-box\">\n<summary>Think you already know this? Five questions, one minute.<\/summary>\n<div class=\"msq-body\">\n<p class=\"msq-intro\">Every answer is on this page. Answer from what you know now; the page fills in the rest.<\/p>\n<ol class=\"msq-list\">\n<li class=\"msq-q\" data-q=\"1\" data-answer=\"b\" data-title=\"What are the symptoms of ovarian cancer after menopause?\" data-section=\"#what-are-the-symptoms-of-ovarian-cancer-after-menopause\">\n<p class=\"msq-question\">1. Which of the following is one of the four main symptoms of ovarian cancer listed by the NHS and NICE?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 1 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">Hot flushes and night sweats<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">Feeling full quickly after eating<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">Sudden joint pain and stiffness<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>The four main symptoms include feeling full quickly, bloating, pelvic or tummy pain, and needing to pee more urgently or often, as detailed on the <a href=\"https:\/\/www.nhs.uk\/conditions\/ovarian-cancer\/symptoms\/\" target=\"_blank\" rel=\"noopener\">NHS ovarian cancer symptoms page<\/a>. <a class=\"msq-section\" href=\"#what-are-the-symptoms-of-ovarian-cancer-after-menopause\">Read the section<\/a><\/p>\n<\/li>\n<li class=\"msq-q\" data-q=\"2\" data-answer=\"a\" data-title=\"How is this different from ordinary menopause bloating?\" data-section=\"#how-is-this-different-from-ordinary-menopause-bloating\">\n<p class=\"msq-question\">2. Why does NICE guidance recommend testing for new IBS type symptoms in women aged 50 or over?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 2 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">IBS rarely starts for the first time at this age<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">IBS is always caused by hormonal changes in menopause<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">IBS symptoms are completely different from ovarian cancer symptoms<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>Recommendation 1.5.5 asks for tests in anyone aged 50 or over with symptoms suggesting IBS in the last 12 months, because IBS rarely presents for the first time at that age, as set out in <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE NG12 on ovarian cancer<\/a>. <a class=\"msq-section\" href=\"#how-is-this-different-from-ordinary-menopause-bloating\">Read the section<\/a><\/p>\n<\/li>\n<li class=\"msq-q\" data-q=\"3\" data-answer=\"b\" data-title=\"Where does more than 12 times a month come from?\" data-section=\"#where-does-more-than-12-times-a-month-come-from\">\n<p class=\"msq-question\">3. According to the Goff symptom index, how long must symptoms have been present to fit the positive criteria?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 3 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">For more than five years<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">For less than a year<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">For exactly two years<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>The index counts as positive when symptoms occur more than 12 times a month and have been present for less than a year, as published by <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17154394\/\" target=\"_blank\" rel=\"noopener\">Goff and colleagues, writing in the journal Cancer<\/a>. <a class=\"msq-section\" href=\"#where-does-more-than-12-times-a-month-come-from\">Read the section<\/a><\/p>\n<\/li>\n<li class=\"msq-q\" data-q=\"4\" data-answer=\"b\" data-title=\"What test does the pattern lead to?\" data-section=\"#what-test-does-the-pattern-lead-to\">\n<p class=\"msq-question\">4. Since the April 2026 update to NICE NG12, what CA125 level leads to an urgent scan for a woman aged 60 to 69?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 4 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">35 IU\/ml or greater, the same as every other age<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">24 IU\/ml or greater<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">50 IU\/ml or greater<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>Recommendation 1.5.9 and its Table 1 now set thresholds by age, 24 IU\/ml or greater at 60 to 69, replacing the single 35 cut off, in <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE NG12 on ovarian cancer<\/a>. <a class=\"msq-section\" href=\"#what-test-does-the-pattern-lead-to\">Read the section<\/a><\/p>\n<\/li>\n<li class=\"msq-q\" data-q=\"5\" data-answer=\"b\" data-title=\"Why is there no screening test to catch it earlier?\" data-section=\"#why-is-there-no-screening-test-to-catch-it-earlier\">\n<p class=\"msq-question\">5. What did the UKCTOCS clinical trial find regarding ovarian cancer screening for women without symptoms?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 5 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">Screening significantly reduced deaths over 16 years<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">Screening found some cancers earlier but did not significantly reduce deaths<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">Screening was unable to find any early stage cancers<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>The large scale trial showed that while screening detected some cancers earlier, it did not significantly reduce deaths, as reported in <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33991479\/\" target=\"_blank\" rel=\"noopener\">UKCTOCS, reported in The Lancet in 2021<\/a>. <a class=\"msq-section\" href=\"#why-is-there-no-screening-test-to-catch-it-earlier\">Read the section<\/a><\/p>\n<\/li>\n<\/ol>\n<div class=\"msq-result\" hidden><\/div>\n<\/div>\n<\/details>\n<script>(function(){\n  if (window.__msqInit) { return; }\n  window.__msqInit = true;\n  var root = document.getElementById('ms-quiz');\n  if (!root) { return; }\n  var meta = { slug: root.getAttribute('data-slug'), category: root.getAttribute('data-category'),\n               list: root.getAttribute('data-list') || '1' };\n  function qs(el, s){ return el.querySelector(s); }\n  function qsa(el, s){ return Array.prototype.slice.call(el.querySelectorAll(s)); }\n  function track(name, params){\n    try { if (typeof gtag === 'function') { var p = params || {}; p.article = meta.slug; gtag('event', name, p); } } catch (e) {}\n  }\n  function jumpList(missed){\n    if (!missed.length) { return ''; }\n    return '<ul class=\"msq-jump\">' + missed.map(function(q){\n      return '<li><a href=\"' + q.getAttribute('data-section') + '\">' + q.getAttribute('data-title') + '<\/a><\/li>';\n    }).join('') + '<\/ul>';\n  }\n  function emailForm(){\n    return '<div class=\"msq-sub\"><p><strong>Get the next one.<\/strong> We publish new articles on ' + meta.category\n      + ' most weeks and recheck this page on Sundays. Email me when a new article goes up or this page changes.<\/p>'\n      + '<form class=\"msq-form\" method=\"post\" action=\"\/mail\/form.php\" novalidate>'\n      + '<input type=\"hidden\" name=\"list\" value=\"' + meta.list + '\">'\n      + '<input type=\"hidden\" name=\"name\" value=\"\">'\n      + '<label class=\"msq-hp\" aria-hidden=\"true\">Leave this empty<input type=\"text\" name=\"website\" tabindex=\"-1\" autocomplete=\"off\"><\/label>'\n      + '<input type=\"email\" name=\"email\" placeholder=\"you@example.com\" required aria-label=\"Email address\" autocomplete=\"email\">'\n      + '<button type=\"submit\" class=\"msq-btn\">Email me the updates<\/button>'\n      + '<a href=\"#\" class=\"msq-no\">No thanks<\/a>'\n      + '<p class=\"msq-privacy\">We store your email and this page\\'s topic, nothing else. Unsubscribe any time.<\/p>'\n      + '<\/form><p class=\"msq-msg\" aria-live=\"polite\"><\/p><\/div>';\n  }\n  \/* The autoresponder always answers 200 with its own page. A \".msg.err\" box means the\n     address was rejected, \"You're subscribed\" means accepted, and a redirect only happens\n     after a successful subscribe. Same reading as the landing pages on the other sites. *\/\n  function sendForm(form){\n    return fetch(form.getAttribute('action'), { method: 'POST', body: new FormData(form), credentials: 'same-origin', redirect: 'manual' })\n      .then(function(res){\n        if (res.type === 'opaqueredirect') { return { status: 'ok' }; }\n        if (res.status === 404) { return { status: 'notlive' }; }\n        if (!res.ok) { throw new Error('HTTP ' + res.status); }\n        return res.text().then(function(t){\n          var doc = new DOMParser().parseFromString(t, 'text\/html');\n          var err = doc.querySelector('.msg.err');\n          if (err) {\n            var m = err.textContent.trim();\n            if (\/something went wrong\/i.test(m)) { throw new Error(m); }\n            return { status: 'rejected', message: m };\n          }\n          if (\/you.re subscribed\/i.test(doc.body.textContent)) { return { status: 'ok' }; }\n          return { status: 'unknown' };\n        });\n      });\n  }\n  function wireForm(sub){\n    var form = qs(sub, '.msq-form'), msg = qs(sub, '.msq-msg');\n    qs(form, '.msq-no').addEventListener('click', function(e){\n      e.preventDefault();\n      sub.innerHTML = '<p class=\"msq-msg\">No problem. The Sunday refresh keeps this page current either way.<\/p>';\n      track('quiz_email', { result: 'declined' });\n    });\n    form.addEventListener('submit', function(e){\n      e.preventDefault();\n      var input = qs(form, 'input[name=email]'), btn = qs(form, '.msq-btn');\n      var email = input.value.trim(); input.value = email;\n      if (!\/^[^\\s@]+@[^\\s@]+\\.[^\\s@]+$\/.test(email)) { msg.textContent = 'That email does not look right.'; return; }\n      btn.disabled = true; btn.textContent = 'Sending';\n      function reset(){ btn.disabled = false; btn.textContent = 'Email me the updates'; }\n      sendForm(form).then(function(r){\n        if (r.status === 'ok' || r.status === 'unknown') {\n          sub.innerHTML = '<p class=\"msq-msg\"><strong>Done.<\/strong> We will email you when the next article on ' + meta.category\n            + ' goes up and when this page changes. If a confirmation email arrives, click it.<\/p>';\n          track('quiz_email', { result: r.status });\n          if (r.status === 'ok') { track('generate_lead', { method: 'quiz' }); }\n        } else if (r.status === 'notlive') {\n          msg.textContent = 'Sign up is not switched on yet for this site. Nothing was stored.'; reset();\n          track('quiz_email', { result: 'notlive' });\n        } else {\n          msg.textContent = r.message || 'Please check the email address and try again.'; reset();\n          track('quiz_email', { result: 'rejected' });\n        }\n      }).catch(function(){\n        msg.textContent = 'Could not reach the sign up service just now. Nothing was stored.'; reset();\n        track('quiz_email', { result: 'error' });\n      });\n    });\n  }\n  function finish(container, mode, score, total, missed){\n    var result = qs(container, '.msq-result');\n    track('quiz_complete', { mode: mode, score: score, total: total });\n    var h;\n    if (mode === 'pre') {\n      h = '<h3>You knew ' + score + ' of ' + total + ' before reading.<\/h3>';\n      h += (score === total) ? '<p>All of them. Read on anyway; the sections below carry the detail behind each answer.<\/p>'\n                             : '<p>The rest is below. Jump straight to what you missed:<\/p>' + jumpList(missed);\n      try { sessionStorage.setItem('msq-pre-' + meta.slug, String(score)); } catch (e) {}\n    } else {\n      var pre = null;\n      try { pre = sessionStorage.getItem('msq-pre-' + meta.slug); } catch (e) {}\n      h = '<h3>You got ' + score + ' of ' + total + '.<\/h3>';\n      if (pre !== null) { h += '<p>Before reading you had ' + pre + ' of ' + total + '.<\/p>'; }\n      if (missed.length) { h += '<p>Worth a second look:<\/p>' + jumpList(missed); }\n      h += emailForm();\n    }\n    result.innerHTML = h; result.hidden = false;\n    if (mode !== 'pre') { wireForm(qs(result, '.msq-sub')); }\n    result.scrollIntoView({ behavior: 'smooth', block: 'nearest' });\n  }\n  function setup(container, mode){\n    var qEls = qsa(container, '.msq-q'), answered = 0, score = 0, missed = [];\n    qEls.forEach(function(q){\n      var answer = q.getAttribute('data-answer'), opts = qsa(q, '.msq-opt'), explain = qs(q, '.msq-explain');\n      q.removeAttribute('data-done'); explain.hidden = true; qs(explain, '.msq-verdict').textContent = '';\n      opts.forEach(function(b){ b.disabled = false; b.classList.remove('is-right', 'is-wrong'); });\n      opts.forEach(function(b){\n        b.addEventListener('click', function(){\n          if (q.getAttribute('data-done')) { return; }\n          q.setAttribute('data-done', '1');\n          var ok = b.getAttribute('data-opt') === answer;\n          opts.forEach(function(o){ o.disabled = true; if (o.getAttribute('data-opt') === answer) { o.classList.add('is-right'); } });\n          if (ok) { score += 1; } else { b.classList.add('is-wrong'); missed.push(q); }\n          qs(explain, '.msq-verdict').textContent = ok ? 'Right. ' : 'Not quite. ';\n          explain.hidden = false;\n          answered += 1;\n          track('quiz_answer', { mode: mode, question: q.getAttribute('data-q'), correct: ok ? 1 : 0 });\n          if (answered === qEls.length) { finish(container, mode, score, qEls.length, missed); }\n        });\n      });\n    });\n  }\n  var box = qs(root, '.msq-box');\n  setup(root, 'pre');\n  if (box) { var skipFirst = box.hasAttribute('data-default-open'); box.addEventListener('toggle', function(){ if (!box.open) { return; } if (skipFirst) { skipFirst = false; return; } track('quiz_open', { mode: 'pre' }); }); }\n  \/* The end block sits far below this script, so it does not exist yet while this runs\n     during parsing. A delegated listener finds it at click time. *\/\n  document.addEventListener('click', function(e){\n    var startBtn = (e.target && e.target.closest) ? e.target.closest('.msq-start-test') : null;\n    if (!startBtn) { return; }\n    var end = startBtn.closest('.msq-end');\n    if (!end) { return; }\n    var mount = qs(end, '.msq-mount');\n    var clone = qs(root, '.msq-body').cloneNode(true);\n    var intro = qs(clone, '.msq-intro');\n    if (intro) { intro.textContent = 'The same five questions, now that you have read the page.'; }\n    var res = qs(clone, '.msq-result'); if (res) { res.hidden = true; res.innerHTML = ''; }\n    mount.innerHTML = ''; mount.appendChild(clone);\n    setup(mount, 'test');\n    startBtn.hidden = true;\n    track('quiz_open', { mode: 'test' });\n    mount.scrollIntoView({ behavior: 'smooth', block: 'start' });\n    var first = qs(mount, '.msq-opt'); if (first) { first.focus({ preventScroll: true }); }\n  });\n  \/* Shared tool behaviour: checklists remember their ticks on this device, and a chooser\n     shows the result for the option picked. Calculators carry their own small script. *\/\n  function initTools(){\n    qsa(document, '.msq-check').forEach(function(box){\n      var key = 'msq-check-' + meta.slug + '-' + (box.getAttribute('data-id') || 'x');\n      var boxes = qsa(box, 'input[type=checkbox]'), count = qs(box, '.msq-check-count');\n      var yes = qs(box, '.msq-verdict-yes'), no = qs(box, '.msq-verdict-no');\n      var saved = {};\n      try { saved = JSON.parse(localStorage.getItem(key) || '{}'); } catch (e) {}\n      boxes.forEach(function(cb, i){ if (saved[i]) { cb.checked = true; } });\n      function refresh(){\n        var n = boxes.filter(function(cb){ return cb.checked; }).length, state = {};\n        boxes.forEach(function(cb, i){ if (cb.checked) { state[i] = 1; } });\n        try { localStorage.setItem(key, JSON.stringify(state)); } catch (e) {}\n        if (count) { count.textContent = n + ' of ' + boxes.length + (box.getAttribute('data-verb') || ' done'); }\n        if (yes && no) { yes.hidden = n === 0; no.hidden = n !== 0; }\n      }\n      boxes.forEach(function(cb){ cb.addEventListener('change', function(){ refresh(); track('tool_check', { tool: box.getAttribute('data-id') }); }); });\n      refresh();\n    });\n    qsa(document, '.msq-choose').forEach(function(box){\n      var results = qsa(box, '.msq-choice-result');\n      qsa(box, 'input[type=radio]').forEach(function(r){\n        r.addEventListener('change', function(){\n          results.forEach(function(el){ el.hidden = el.getAttribute('data-for') !== r.value; });\n          track('tool_choose', { tool: box.getAttribute('data-id'), choice: r.value });\n        });\n      });\n    });\n  }\n  \/\/ read progress: how far down the article the reader has scrolled, fired once per quarter\n  (function(){\n    var art = root.closest('article') || root.parentNode, fired = {};\n    function check(){\n      var top = art.getBoundingClientRect().top + window.pageYOffset, h = art.offsetHeight || 1;\n      var seen = (window.pageYOffset + window.innerHeight - top) \/ h * 100;\n      [25, 50, 75, 100].forEach(function(m){ if (seen >= m && !fired[m]) { fired[m] = true; track('read_progress', { percent: m }); } });\n    }\n    window.addEventListener('scroll', check, { passive: true }); window.addEventListener('load', check);\n  })();\n  if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', initTools); } else { initTools(); }\n})();<\/script>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Most symptom lists stop before that last sentence, which is a shame, because a list of bloating, fullness, tummy pain and trips to the loo describes half the population after a big lunch. What guidance uses is the pattern: how often, how new, how many together. This article sets that pattern out. It cannot tell anyone what their own symptoms mean.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-are-the-symptoms-of-ovarian-cancer-after-menopause\">What are the symptoms of ovarian cancer after menopause?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The <a href=\"https:\/\/www.nhs.uk\/conditions\/ovarian-cancer\/symptoms\/\" target=\"_blank\" rel=\"noopener\">NHS ovarian cancer symptoms page<\/a>, reviewed on 17 November 2025, names four main symptoms: a swollen tummy or feeling bloated; pain or tenderness in the tummy or the area between the hips; no appetite or feeling full quickly after eating; and an urgent need to pee or needing to pee more often. It lists other symptoms too: indigestion, constipation or diarrhoea, back pain, feeling tired all the time, losing weight without trying, and unusual bleeding from the vagina. Constipation on its own far more often has another cause, and our <a href=\"https:\/\/pauseproof.com\/articles\/menopause-and-constipation\/\">guide to menopause and constipation and the NHS bowel warning signs<\/a> sets out when a change still needs a GP.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The UK guideline for GPs uses the same four. <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE guideline NG12 on suspected cancer<\/a>, last updated on 15 April 2026, tells GPs to carry out tests if a woman, especially if 50 or over, reports persistent abdominal distension, early satiety or loss of appetite, pelvic or abdominal pain, or increased urinary urgency or frequency on a persistent or frequent basis. What changes with age is the likelihood: the <a href=\"https:\/\/www.cancer.org\/cancer\/types\/ovarian-cancer\/about\/key-statistics.html\" target=\"_blank\" rel=\"noopener\">American Cancer Society<\/a> reports that roughly half of women diagnosed are 63 or older.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bleeding is the exception to every rule about patterns. Any bleeding after twelve months without a period gets checked, once is enough, and we explain why in <a href=\"https:\/\/pauseproof.com\/articles\/bleeding-after-menopause\/\">why even spotting after menopause gets checked<\/a>. That twelve month line is also the only thing that dates menopause at all, which is the subject of <a href=\"https:\/\/pauseproof.com\/articles\/how-do-you-know-if-you-have-started-menopause\/\">how you know if you have started menopause<\/a>. If those twelve months arrived before you turned 45, <a href=\"https:\/\/pauseproof.com\/articles\/early-menopause-symptoms\/\">early menopause symptoms and why the timing matters<\/a> covers the separate questions that raises.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"how-is-this-different-from-ordinary-menopause-bloating\">How is this different from ordinary menopause bloating?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Bloating is common, which is exactly the problem. The <a href=\"https:\/\/www.gastrojournal.org\/article\/S0016-5085(23)00826-0\/fulltext\" target=\"_blank\" rel=\"noopener\">Rome Foundation Global Epidemiology Study<\/a> surveyed 51,425 people in 26 countries and found 17 per cent reporting bloating at least weekly. Our article on <a href=\"https:\/\/pauseproof.com\/articles\/perimenopause-bloating-digestive-symptoms\/\">the gut changes that turn up in midlife<\/a> covers how thin the evidence is for blaming hormones.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The table below sets the two patterns side by side. It summarises how guidance sorts who is offered tests, not a way to sort yourself: plenty of people in the left column still get examined, and asking is always allowed.<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><thead><tr><th>What to look at<\/th><th>Pattern that is common and often benign<\/th><th>Pattern the guidance treats as a reason to test<\/th><\/tr><\/thead><tbody><tr><td>How often<\/td><td>Some days, some weeks, often after particular meals<\/td><td>Persistent or frequent, particularly more than 12 times a month (<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83852\/\" target=\"_blank\" rel=\"noopener\">NICE CG122<\/a>)<\/td><\/tr><tr><td>How new<\/td><td>Familiar for years, with the same ups and downs<\/td><td>New, or clearly changed, within the last year (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17154394\/\" target=\"_blank\" rel=\"noopener\">Goff symptom index<\/a>)<\/td><\/tr><tr><td>Bowel symptoms<\/td><td>A long history of IBS type symptoms<\/td><td>Symptoms suggesting IBS within the last 12 months at 50 or over, because IBS rarely starts at that age (<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555330\/\" target=\"_blank\" rel=\"noopener\">NICE NG12<\/a>)<\/td><\/tr><tr><td>How many together<\/td><td>One symptom on its own<\/td><td>Two or more of bloating, fullness, pain and urinary change, though any one that persists counts under NICE<\/td><\/tr><tr><td>Direction<\/td><td>Settles, then returns in a familiar way<\/td><td>Getting more frequent or more persistent, which NICE names as the reason to go back after a normal test<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1376\" height=\"768\" src=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-feeling-full.jpg\" alt=\"Barely eaten lunch pushed aside, the early fullness listed among symptoms of ovarian cancer after menopause\" class=\"wp-image-185\" srcset=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-feeling-full.jpg 1376w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-feeling-full-300x167.jpg 300w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-feeling-full-1024x572.jpg 1024w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-feeling-full-768x429.jpg 768w\" sizes=\"auto, (max-width: 1376px) 100vw, 1376px\" \/><figcaption class=\"wp-block-image__caption\">Feeling full quickly is one of the four main symptoms named by NICE and the NHS.<\/figcaption><\/figure>\n\n\n\n<div class=\"msq-tool msq-check\" data-id=\"symptoms-pattern-checklist\" data-verb=\" checked\">\n<h3>Symptom Pattern Checklist<\/h3>\n<p>These are the things NICE NG12 asks GPs to look for when deciding whether to offer tests. Ticking them does not tell anyone what their symptoms mean.<\/p>\n<label><input type=\"checkbox\">Bloating or swelling that is persistent or frequent<\/label>\n<label><input type=\"checkbox\">Feeling full quickly or having a loss of appetite<\/label>\n<label><input type=\"checkbox\">Pelvic or abdominal pain or tenderness<\/label>\n<label><input type=\"checkbox\">Urgent need to pee or needing to pee more often<\/label>\n<label><input type=\"checkbox\">Symptoms happening more than 12 times a month<\/label>\n<label><input type=\"checkbox\">Symptoms that are new or clearly changed within the last year<\/label>\n<label><input type=\"checkbox\">Symptoms that suggest IBS, first appearing in the last 12 months, at 50 or over<\/label>\n<p class=\"msq-check-count\"><\/p>\n<p class=\"msq-note\">Ticks are saved on this device only.<\/p>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"where-does-more-than-12-times-a-month-come-from\">Where does more than 12 times a month come from?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">From a symptom study published in 2007. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17154394\/\" target=\"_blank\" rel=\"noopener\">Goff and colleagues, writing in the journal Cancer<\/a>, compared women with ovarian cancer against women without it and found that four symptoms were linked to the cancer: pelvic or abdominal pain, urinary urgency or frequency, increased abdominal size or bloating, and difficulty eating or feeling full. Their index counted as positive when any of them happened more than 12 times a month and had been present for less than a year.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In the confirmatory sample it picked up 56.7% of early stage cancers and 79.5% of advanced ones. Its specificity was 90% in women over 50, which means about 1 in 10 women in that comparison group who did not have cancer met the criteria anyway. A symptom rule is a filter for who gets a test. It is not a diagnosis in either direction.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Here is how the threshold reads across the sources, each checked on 14 September 2026.<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><thead><tr><th>Source<\/th><th>What it says, in its own terms<\/th><th>Version read<\/th><\/tr><\/thead><tbody><tr><td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555330\/\" target=\"_blank\" rel=\"noopener\">NICE NG12, suspected cancer<\/a><\/td><td>Tests if symptoms are persistent or frequent, particularly more than 12 times per month, especially at 50 or over. Urgent referral if an examination finds ascites or a pelvic or abdominal mass<\/td><td>January 2026 text<\/td><\/tr><tr><td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83852\/\" target=\"_blank\" rel=\"noopener\">NICE CG122, ovarian cancer<\/a><\/td><td>Same four symptoms and wording. Consider tests for unexplained weight loss, fatigue or changes in bowel habit<\/td><td>2011 recommendations, list read on NCBI Bookshelf<\/td><\/tr><tr><td><a href=\"https:\/\/www.nhs.uk\/conditions\/ovarian-cancer\/symptoms\/\" target=\"_blank\" rel=\"noopener\">NHS symptoms page<\/a><\/td><td>See a GP with any symptom, or again if symptoms have not gone away, are worse or are more frequent<\/td><td>Reviewed 17 November 2025<\/td><\/tr><tr><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17154394\/\" target=\"_blank\" rel=\"noopener\">Goff symptom index<\/a><\/td><td>Any of the symptoms more than 12 times a month, present for less than a year<\/td><td>Cancer, 2007<\/td><\/tr><tr><td><a href=\"https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/ovarian-cancer-screening\" target=\"_blank\" rel=\"noopener\">US Preventive Services Task Force<\/a><\/td><td>Recommends against screening women without symptoms; women with symptoms are outside that recommendation<\/td><td>Grade D, February 2018<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1600\" height=\"900\" src=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/11\/symptoms-of-ovarian-cancer-after-menopause-chart.png\" alt=\"Bar chart showing Goff symptom index detection rates and specificity\" class=\"wp-image-1086\" srcset=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/11\/symptoms-of-ovarian-cancer-after-menopause-chart.png 1600w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/11\/symptoms-of-ovarian-cancer-after-menopause-chart-300x169.png 300w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/11\/symptoms-of-ovarian-cancer-after-menopause-chart-1024x576.png 1024w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/11\/symptoms-of-ovarian-cancer-after-menopause-chart-768x432.png 768w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/11\/symptoms-of-ovarian-cancer-after-menopause-chart-1536x864.png 1536w\" sizes=\"auto, (max-width: 1600px) 100vw, 1600px\" \/><figcaption class=\"wp-block-image__caption\">Data from the Goff symptom index study published in the journal Cancer<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-test-does-the-pattern-lead-to\">What test does the pattern lead to?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In the UK, a blood test first for anyone aged 40 or over. NICE amended the ovarian cancer section of <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NG12, its guideline on suspected cancer<\/a>, in April 2026, and recommendation 1.5.9 now ties the CA125 level that triggers an urgent, direct access ultrasound scan of the abdomen and pelvis to age. Before that update one figure, 35 IU\/ml, applied at every age. From 50 upwards, every age band now has a lower trigger. If the scan suggests ovarian cancer, the woman is referred to a gynaecological cancer service on a suspected cancer pathway.<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><thead><tr><th>Age<\/th><th>CA125 that leads to an urgent scan, since April 2026<\/th><th>Before April 2026<\/th><\/tr><\/thead><tbody><tr><td>39 or under<\/td><td>CA125 not used on its own; consider an urgent scan for persistent symptoms (1.5.6, <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE NG12<\/a>)<\/td><td>35 IU\/ml or greater<\/td><\/tr><tr><td>40 to 49<\/td><td>35 IU\/ml or greater (1.5.9, <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE NG12<\/a>)<\/td><td>35 IU\/ml or greater<\/td><\/tr><tr><td>50 to 59<\/td><td>31 IU\/ml or greater (1.5.9, <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE NG12<\/a>)<\/td><td>35 IU\/ml or greater<\/td><\/tr><tr><td>60 to 69<\/td><td>24 IU\/ml or greater (1.5.9, <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE NG12<\/a>)<\/td><td>35 IU\/ml or greater<\/td><\/tr><tr><td>70 to 79<\/td><td>25 IU\/ml or greater (1.5.9, <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE NG12<\/a>)<\/td><td>35 IU\/ml or greater<\/td><\/tr><tr><td>80 and over<\/td><td>31 IU\/ml or greater (1.5.9, <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/Recommendations-organised-by-site-of-cancer#ovarian-cancer\" target=\"_blank\" rel=\"noopener\">NICE NG12<\/a>)<\/td><td>35 IU\/ml or greater<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">NICE NG12 recommendations 1.5.6 to 1.5.9 and Table 1, last updated 15 April 2026, read on 17 November 2026.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The committee explains its reasoning under the recommendations. Moderate certainty evidence showed that in women over 50 the CA125 level predicts well enough to justify a strong recommendation for a scan, and the committee chose not to call a result below 35 normal. Pages written before April 2026 still give 35 as the single cut off. This one did too, until we checked the guideline again on 17 November 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">CA125 is a pointer, not a verdict. A <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7592785\/\" target=\"_blank\" rel=\"noopener\">study of 50,780 women tested in UK primary care, by Funston and colleagues in PLOS Medicine, 2020<\/a>, found that among women aged 50 and over with a CA125 of 35 or more, 15.2% were diagnosed with ovarian cancer within a year, and 20.4% with a different cancer. Most raised results were neither. That study used the old single cut off, so its figures describe the 35 line, not the new age bands.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A result below the threshold is not the end of the conversation either. Under recommendation 1.5.11, when CA125 does not meet the threshold for the woman&#8217;s age, or meets it but the scan is normal, the GP looks for other causes, and if none is found, advises her to come back if her symptoms become more frequent or persistent.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"why-is-there-no-screening-test-to-catch-it-earlier\">Why is there no screening test to catch it earlier?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Because the largest trial to try it did not save lives. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33991479\/\" target=\"_blank\" rel=\"noopener\">UKCTOCS, reported in The Lancet in 2021<\/a>, followed more than 200,000 women aged 50 to 74 for around 16 years. Screening found some cancers earlier but did not significantly reduce deaths. The <a href=\"https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/ovarian-cancer-screening\" target=\"_blank\" rel=\"noopener\">US Preventive Services Task Force<\/a> recommends against screening women who have no symptoms and no known high risk hereditary syndrome. That leaves symptoms, and their pattern, as the main route to a test.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"how-common-is-ovarian-cancer-after-menopause\">How common is ovarian cancer after menopause?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Less common than the worry it causes, and more common with age. The <a href=\"https:\/\/www.cancer.org\/cancer\/types\/ovarian-cancer\/about\/key-statistics.html\" target=\"_blank\" rel=\"noopener\">American Cancer Society&#8217;s estimates for 2026<\/a> put new US diagnoses at about 21,010 this year and a woman&#8217;s lifetime risk at about 1 in 91. In the UK, <a href=\"https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\" target=\"_blank\" rel=\"noopener\">Cancer Research UK<\/a> counts 7,748 new cases a year.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The figure that explains why this article spends so long on patterns is how the cancer gets found. In England in 2022, 38% of cases with a known stage were diagnosed at stage I or II. Of cases diagnosed in England in 2019, 34% came through an urgent suspected cancer referral and 29% through an emergency presentation, meaning the diagnosis was made through an emergency route such as A&amp;E rather than a planned referral.<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><thead><tr><th>Figure<\/th><th>Number<\/th><th>Source and period<\/th><\/tr><\/thead><tbody><tr><td>New diagnoses a year, US<\/td><td>About 21,010<\/td><td><a href=\"https:\/\/www.cancer.org\/cancer\/types\/ovarian-cancer\/about\/key-statistics.html\" target=\"_blank\" rel=\"noopener\">American Cancer Society<\/a>, estimate for 2026<\/td><\/tr><tr><td>Lifetime risk, US<\/td><td>About 1 in 91<\/td><td><a href=\"https:\/\/www.cancer.org\/cancer\/types\/ovarian-cancer\/about\/key-statistics.html\" target=\"_blank\" rel=\"noopener\">American Cancer Society<\/a>, 2026<\/td><\/tr><tr><td>Women diagnosed who are 63 or older, US<\/td><td>About half<\/td><td><a href=\"https:\/\/www.cancer.org\/cancer\/types\/ovarian-cancer\/about\/key-statistics.html\" target=\"_blank\" rel=\"noopener\">American Cancer Society<\/a>, 2026<\/td><\/tr><tr><td>New cases a year, UK<\/td><td>7,748<\/td><td><a href=\"https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\" target=\"_blank\" rel=\"noopener\">Cancer Research UK<\/a>, 2019 and 2021 to 2022<\/td><\/tr><tr><td>Staged cases found at stage I or II, England<\/td><td>38%<\/td><td><a href=\"https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\" target=\"_blank\" rel=\"noopener\">Cancer Research UK<\/a>, 2022<\/td><\/tr><tr><td>Diagnosed through an urgent suspected cancer referral, England<\/td><td>34%<\/td><td><a href=\"https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\" target=\"_blank\" rel=\"noopener\">Cancer Research UK<\/a>, 2019<\/td><\/tr><tr><td>Diagnosed through an emergency presentation, England<\/td><td>29%<\/td><td><a href=\"https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\" target=\"_blank\" rel=\"noopener\">Cancer Research UK<\/a>, 2019<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">Figures as published by the American Cancer Society and Cancer Research UK, read on 17 November 2026.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Those numbers describe populations, not any one person. They do show why the symptom route matters: with no screening programme, a GP appointment for a persistent pattern is the planned way in, and the emergency route is the one nobody wants.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-do-people-who-went-through-this-report\">What do people who went through this report?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">For this article we read two public Reddit threads in full, about 45 comments, and nine accounts of symptoms or outcomes. Two described events more than three years old and are left out. The seven below are what people report, not evidence, and forum posters are not a random sample of anyone.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In a thread in r\/Menopause posted around December 2025, a <a href=\"https:\/\/www.reddit.com\/r\/Menopause\/comments\/1py46pq\/ovarian_concerns\/\" target=\"_blank\" rel=\"noopener\">post-menopausal woman described three months of steady bloating<\/a>, low back pain, needing to pee often, new digestive trouble and tiredness. She said she had raised it with her primary care doctor three times, been put down as anxious and refused a transvaginal scan, and got a pelvic examination booked through urgent care instead. She did not post an outcome. One reply described similar symptoms and a doctor who arranged an ultrasound, a second scan after the first showed an enlarged ovary, and a blood test, with a clear result. Another described a haemorrhaging cyst, with low back pain and spotting, that needed no treatment. A third said her mother&#8217;s similar symptoms were put down to urinary infections, menopause and old scar tissue before stage 3 ovarian cancer was found.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1376\" height=\"768\" src=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-after-appointment.jpg\" alt=\"Woman sitting in a parked car after an appointment about symptoms of ovarian cancer after menopause\" class=\"wp-image-186\" srcset=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-after-appointment.jpg 1376w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-after-appointment-300x167.jpg 300w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-after-appointment-1024x572.jpg 1024w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/ovarian-cancer-symptoms-after-menopause-after-appointment-768x429.jpg 768w\" sizes=\"auto, (max-width: 1376px) 100vw, 1376px\" \/><figcaption class=\"wp-block-image__caption\">People describe repeat visits, clear results and late diagnoses, which is why the pattern matters.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">In r\/Ovariancancer, under a <a href=\"https:\/\/www.reddit.com\/r\/Ovariancancer\/comments\/1ogxphx\/signssymptoms\/\" target=\"_blank\" rel=\"noopener\">post sharing a symptoms graphic<\/a> around October 2025, one commenter described constant constipation or diarrhoea and feeling full however little she ate. Another described 16 months of knowing something was wrong, with doctors unable to explain it, before arriving at an emergency department with fluid in her abdomen and a stage 3 diagnosis. A third cut against the whole list: she said she had none of the symptoms on the graphic, was breathless from fluid around a lung, and was diagnosed at stage IV. Her worry was that women without the listed symptoms would think they were fine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Where the accounts agree with the guidance: the symptoms people described were mostly persistent, new, and several at once, and gut symptoms were often attributed to something else first, which is the exact trap NICE&#8217;s rule on new IBS type symptoms at 50 is written to catch. Where they part company: the guidance says little about repeat visits that go nowhere, and one account describes a presentation the main list would not have flagged. None of these stories says anything about what another person&#8217;s symptoms are.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-if-the-tests-were-normal-and-the-symptoms-carry-on\">What if the tests were normal and the symptoms carry on?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Then they are worth raising again. NICE builds that return visit into the pathway, and the NHS page says to go back if symptoms have not gone away, are worse or are more frequent. A written record makes that second appointment more useful, and <a href=\"https:\/\/pauseproof.com\/articles\/perimenopause-symptom-diary\/\">what to write down in a symptom diary<\/a> sets out one a doctor can use. For the other changes that carry on, see <a href=\"https:\/\/pauseproof.com\/articles\/post-menopausal-symptoms\/\">what continues after menopause and what eases<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If any of these symptoms are happening most days, that is a reason to book a GP appointment. Sudden severe abdominal pain, or a swollen abdomen with breathlessness, is a reason to seek urgent medical help rather than wait. If you are not sure whether your symptoms fit the pattern but you are still worried, that is also a reason to book.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"frequently-asked-questions\">Frequently asked questions<\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list \">\n<div id=\"faq-q-1\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Is bloating after menopause usually a sign of ovarian cancer?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>No. Bloating is common at every age, and the Rome Foundation study found 17 per cent of people reporting it at least weekly. Guidance looks at the pattern: bloating that is persistent or frequent, particularly more than 12 times a month, and new. Only an examination and tests can say what is causing it.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-2\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Can a normal CA125 blood test rule out ovarian cancer?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Not on its own. NICE says that after a normal CA125, the GP looks for other causes and, if none is found, advises the woman to return if symptoms become more frequent or persistent. A normal result describes the day the blood was taken.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-3\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Does ovarian cancer cause bleeding after menopause?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>The NHS lists unusual vaginal bleeding among the other symptoms of ovarian cancer, and among the less common causes of bleeding after menopause. Whatever the cause, any bleeding after twelve months without a period needs a doctor, even if it happened once.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-4\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Is back pain on its own a symptom to worry about?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Back pain appears on the NHS list of other symptoms, not the four main ones, and it has many common causes. It carries more weight alongside the main symptoms, or when it is new and persistent. Back pain that is severe or getting worse is worth a GP appointment whatever the cause.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-5\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Why does age 50 keep coming up in the guidance?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Risk rises with age: roughly half of women diagnosed in the US are 63 or older, according to the American Cancer Society. NICE also says IBS rarely starts for the first time in women aged 50 or over, so new bowel symptoms at that age get tests for ovarian cancer. Symptoms under 50 still count.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-6\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Does family history change any of this?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>It changes the screening picture. The US Preventive Services Task Force recommendation against screening does not cover women with a known high risk hereditary cancer syndrome, who are assessed separately. A family history of ovarian or breast cancer is worth mentioning at any appointment about these symptoms.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<div class=\"msq-end\" id=\"ms-quiz-end\">\n<p><strong>Finished the page?<\/strong> The same five questions from the top, to see what stuck.<\/p>\n<button type=\"button\" class=\"msq-btn msq-start-test\">Test Your Understanding of This Article<\/button>\n<div class=\"msq-mount\"><\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><em>This article is general information, not medical advice, and is not a substitute for care from a qualified healthcare professional. Speak to your doctor about your own situation.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bloating, fullness, pain and needing to pee are common. What guidance uses to decide who gets tested is how often, how new and how many together, and what people who went through it report.<\/p>\n","protected":false},"author":1,"featured_media":184,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","rank_math_title":"Symptoms of Ovarian Cancer After Menopause: When to Act","rank_math_description":"Symptoms of ovarian cancer after menopause include bloating, fullness, pelvic pain and urgency. NICE says test when they occur 12+ times a month.","rank_math_focus_keyword":"symptoms of ovarian cancer after menopause","rank_math_canonical_url":"","rank_math_breadcrumb_title":"","rank_math_facebook_title":"","rank_math_facebook_description":"","rank_math_facebook_image":"","rank_math_twitter_title":"","rank_math_twitter_description":"","rank_math_twitter_image":"","rank_math_pillar_content":"","rank_math_robots":[],"rank_math_advanced_robots":[]},"categories":[3],"tags":[],"class_list":["post-187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-talking-to-your-doctor"],"_links":{"self":[{"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/posts\/187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/comments?post=187"}],"version-history":[{"count":11,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/posts\/187\/revisions"}],"predecessor-version":[{"id":1089,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/posts\/187\/revisions\/1089"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/media\/184"}],"wp:attachment":[{"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/media?parent=187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/categories?post=187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/tags?post=187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}